小剂量肝素佐治小儿重症支气管肺炎的疗效观察

目的探讨小剂量肝素佐治小儿重症支气管肺炎的临床效果。方法68例重症支气管肺炎患儿被随机分为治疗组和对照组，两组患儿均给予吸氧、抗感染、强心及对症治疗，治疗组加用小剂量肝素，治疗后判断疗效，并测定血红细胞压积和血粘度。结果与对照组比较，治疗组治疗后的肺部哆音消失时间减少47．70％，气促恢复时间缩短27．95％，患者的总疗程缩短25．90％，治疗组的总有效率高于对照组，红细胞压积增加了57．69％，血粘度降低27．95％，在统计学上均有显著性差异（P〈0．05或P〈0．01）。结论小剂量肝素佐治小儿重症支气管肺炎可显著提高疗效。

Treatment of infants serious bronchopneumonia with low dose of heparin

Objective To explore the clinical effects of low--dose heparin intervention on infants serious bronchopneumonia. Methods 68 cases of serious bronchopneumonia were randomly divided into therapeutic group and control group, two groups of infants were given oxygen, anti--infection, cardiac treatment and symptomatic treatment, therapeutic group was administered a low dose of heparin, after treatment to determine effect and determination of blood hematocrit and blood viscosity. Results Com- pared with the control group, therapeutic group after treatment of pulmonary got a reduction of disap- pearance time rate by 47.70%, shorten recovery time of hard breathe to 27.95 percent, shorten the overall course of treatment 25.90%, the total effective rates of therapeutic group was superior to the control group, red blood cell hematocrit increased 57.69 percent, blood viscosity reduced 27.95 percent, both had significant difference （P 〈 0.05 or P 〈 0.01）. Conclusions Treatment of infants serious bronchopneumonia with low dose of heparin can significantly improve efficacy.